Literature DB >> 29458684

Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.

Mark G Wise1, Elizabeth Horvath1, Katherine Young2, Daniel F Sahm1, Krystyna M Kazmierczak1.   

Abstract

PURPOSE: To understand the diversity of porin disruption in Klebsiella pneumoniae, the major outer membrane protein (OMP) porins, OmpK35 and OmpK36, were examined in a set of isolates that did not harbour traditional carbapenem-hydrolysing enzymes, but nevertheless tested non-susceptible to ertapenem.
METHODS: A world-wide collection of Klebsiella pneumoniae isolates that were part of the Study for Monitoring Antimicrobial Resistance Trends (SMART) surveillance project over the years 2008-2014 were characterised with regard to their β-lactamase gene carriage and potential permeability defects. Four hundred and eighty-seven isolates that did not carry carbapenemase genes, but were non-susceptible to ertapenem, were investigated by sequence analysis of the genes encoding OmpK35 and OmpK36. Isolates without obvious genetic lesions in either major porin gene were further examined by outer membrane protein SDS-PAGE.
RESULTS: The majority of isolates, 83.0 % (404/487), exhibited clear genetic disruption in either or both of the ompK35 and ompK36 genes. Among the proportion of the collection with the highest ertapenem MIC value (>4 mg l-1), 60.5 % (115/190) showed mutation in both porin genes. Isolates without obvious genetic mutations were examined by SDS-PAGE, and 90.4 % (75/83) were found to lack or show altered expression of at least one of the major OMPs when compared to an ertapenem sensitive control strain.
CONCLUSION: This study illustrates that porin deficiency in Klebsiella pneumoniae is a widespread phenomenon, and in combination with ESBLs and/or AmpC enzymes, likely accounts for the elevated ertapenem MICs observed in this study.

Entities:  

Keywords:  Klebsiella pneumoniae; antimicrobial resistance; ertapenem; permeability; porin

Mesh:

Substances:

Year:  2018        PMID: 29458684     DOI: 10.1099/jmm.0.000691

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  16 in total

1.  Ceftazidime-Avibactam Resistance Associated with Increased bla KPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae.

Authors:  Marco Coppi; Vincenzo Di Pilato; Francesco Monaco; Tommaso Giani; Pier Giulio Conaldi; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

Review 2.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

3.  An outbreak of ertapenem-resistant, carbapenemase-negative and porin-deficient ESBL-producing Klebsiella pneumoniae complex.

Authors:  Mihaela Matovina; Maja Abram; Davorka Repac-Antić; Samira Knežević; Marina Bubonja-Šonje
Journal:  Germs       Date:  2021-06-02

4.  Survey on Carbapenem-Resistant Bacteria in Pigs at Slaughter and Comparison with Human Clinical Isolates in Italy.

Authors:  Silvia Bonardi; Clotilde Silvia Cabassi; Gerardo Manfreda; Antonio Parisi; Enrico Fiaccadori; Alice Sabatino; Sandro Cavirani; Cristina Bacci; Martina Rega; Costanza Spadini; Mattia Iannarelli; Cecilia Crippa; Ferdinando Ruocco; Frédérique Pasquali
Journal:  Antibiotics (Basel)       Date:  2022-06-07

5.  In-Human Multiyear Evolution of Carbapenem-Resistant Klebsiella pneumoniae Causing Chronic Colonization and Intermittent Urinary Tract Infections: A Case Study.

Authors:  Michelle Kalu; Karen Tan; Marquerita Algorri; Peter Jorth; Annie Wong-Beringer
Journal:  mSphere       Date:  2022-05-09       Impact factor: 5.029

6.  Analysis of Susceptibilities of Carbapenem Resistant Enterobacterales to Colistin in Intra-Abdominal, Respiratory and Urinary Tract Infections from 2015 to 2017.

Authors:  Hui Zhang; Jingjia Zhang; Yue Kang; Qiwen Yang; Yingchun Xu
Journal:  Infect Drug Resist       Date:  2020-06-23       Impact factor: 4.003

Review 7.  Two Component Regulatory Systems and Antibiotic Resistance in Gram-Negative Pathogens.

Authors:  Anjali Y Bhagirath; Yanqi Li; Rakesh Patidar; Katherine Yerex; Xiaoxue Ma; Ayush Kumar; Kangmin Duan
Journal:  Int J Mol Sci       Date:  2019-04-10       Impact factor: 5.923

8.  Identification of L169P mutation in the omega loop of KPC-3 after a short course of ceftazidime/avibactam.

Authors:  Carolina Venditti; Carla Nisii; Milva Ballardini; Marcello Meledandri; Antonino Di Caro
Journal:  J Antimicrob Chemother       Date:  2019-08-01       Impact factor: 5.790

9.  OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo.

Authors:  Joshua L C Wong; Maria Romano; Louise E Kerry; Hok-Sau Kwong; Wen-Wen Low; Stephen J Brett; Abigail Clements; Konstantinos Beis; Gad Frankel
Journal:  Nat Commun       Date:  2019-09-02       Impact factor: 14.919

10.  Reduced Susceptibility to Carbapenems in a Klebsiella pneumoniae Clinical Isolate Producing SCO-1 and CTX-M-15 β-Lactamases Together with OmpK35 and OmpK36 Porin Deficiency.

Authors:  Carolina Venditti; Ornella Butera; Anna Proia; Luigi Rigacci; Bruno Mariani; Gabriella Parisi; Francesco Messina; Alessandro Capone; Carla Nisii; Antonino Di Caro
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.